Aedifica NV/SA: Publication relating to a transparency notification Please find below a press release from Aedifica (a public regulated real estate company under Belgian law, listed on Euronext Brussels and Euronext Amsterdam), regarding a publication relating to a transparency notification from BlackRock, Inc. Attachments
AB InBev: $3bn in the can; Aedifica: €108.5m investments at a 6-7% yield; Kinepolis: December US box office revenue down 2%, France visitors up 1%, Avatar below expectations; TomTom: Starting the year with CES fireworks; WDP: €58m investment in Le Havre and €35m disposal in Liège.
Galapagos announced that the previously reported works council consultation process regarding the wind-down of cell therapy activities has now been completed and its Board of Directors has decided to initiate the wind-down of the company's cell therapy activities. This decision follows a strategic review and sale process in 2025 where no viable offers emerged. We believe the wind-down creates clarity and, once completed, will allow management to move forward with their plan of building a new pip...
Aedifica announced € 108.5m new healthcare investments across Europe in a mixture of new forward funded developments, extensions and acquisitions. Aedifica still awaits the approval of the Belgian competition authorities (BCA) to open its exchange period. In our timeline, a decision is expected by 15/01. As a remedy, Aedifica suggested € 300.0m Belgian asset disposals in the coming years. As argued in earlier notes (See: better too early than sorry), Aedifica needs new investments at 6.5% net yi...
WDP started 2026 well with the acquisition of a prime logistics site in the Port of Le Havre, France's main container terminal, for €58m. At the same time, WDP disposed of a vacant asset in Liège (Airport), Belgium, generating €35m. Both are on long term concession land. The Le Havre site includes two Grade A logistics buildings (65k sqm) and a 40k sqm container yard, fully let to Seafrigo under a triple net lease until 2033. This investment yields a 6.0% NOI and strengthens WDP's critical mass ...
Fagron announces the completion of Purifarma Regulated information - inside informationNazareth (Belgium)/Rotterdam (The Netherlands), 6 January 2026 – 7:00 AM CET Fagron announces the completion of Purifarma Fagron, the leading global player in pharmaceutical compounding, is pleased to announce the completion of Purifarma in Brazil, an important milestone in executing our disciplined M&A strategy. The completion of this transaction follows competition clearance by CADE, the Brazilian antitrust authority, last October, and will strengthen Fagron’s scalable, high-quality platform, in line ...
Fagron kondigt de afronding van de overname van Purifarma aan Gereglementeerde informatie - voorkennisNazareth (België)/Rotterdam (Nederland), 6 januari 2026 – 7:00 AM CET Fagron kondigt de afronding van de overname van Purifarma aan Fagron, de toonaangevende wereldwijde speler in farmaceutische bereidingen, is verheugd om de afronding van de overname van Purifarma in Brazilië aan te kondigen. Een belangrijke mijlpaal in de uitvoering van onze gedisciplineerde M&A-strategie. De afronding van Purifarma volgt op de goedkeuring van CADE, de Braziliaanse mededingingsautoriteit, in oktober vo...
Galapagos Announces Board Decision to Initiate Wind-Down of Cell Therapy Activities Mechelen, Belgium; January 5, 2026, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced that the works council consultation process regarding the wind-down of cell therapy activities has been completed and its Board of Directors has decided to initiate the wind-down of the Company’s cell therapy activities. On , Galapagos announced its intention to wind down its cell therapy activities following a comprehensive strategic review and sale process, including an exploration of potential divestment...
Galapagos kondigt besluit van de Raad van Bestuur aan om de afbouw van de celtherapieactiviteiten te starten Mechelen, België; 5 januari 2026, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) heeft vandaag bekendgemaakt dat de overlegprocedures met de ondernemingsraden met betrekking tot de afbouw van de celtherapieactiviteiten zijn afgerond en dat de Raad van Bestuur heeft besloten de afbouw van de celtherapieactiviteiten van het bedrijf te starten. Op kondigde Galapagos aan dat het van plan was zijn celtherapieactiviteiten af te bouwen na een uitgebreide strategische evaluatie en ee...
ARGAN: RENTAL INCOME (+7%) AND APPRAISED PORTFOLIO (+4%) - 2025 WAS FIRMLY ON TRACK FOR GROWTH! Quarterly financial information – Neuilly-sur-Seine, Monday, January 5, 2026 – 5.45 pm Rental income (+7%) and appraised portfolio (+4%): 2025 was firmly on track for growth! Rental income (IFRS) as at December 31, 2025 (unaudited figures) € million20252024Trends1st quarter (Jan. – March)52.948.1+10%2nd quarter (April – June)52.950.0+6%3rd quarter (Jul. – Sept.)52.951.1+4%4th quarter (Oct. – Dec.)53.349.1+9%Yearly total (Jan. – Dec.)212.0198.3+7% €212.0 million in rental income over Full-Year...
ARGAN : REVENUS LOCATIFS (+7 %) ET VALORISATION DU PATRIMOINE (+4 %) - LA CROISSANCE EST AU RENDEZ-VOUS EN 2025 ! Information financière trimestrielle – Neuilly-sur-Seine, lundi 5 janvier 2026 - 17h45 Revenus locatifs (+7 %) et valorisation du patrimoine (+4 %) : la croissance est au rendez-vous en 2025 ! Revenus locatifs (IFRS) au 31 décembre 2025 (chiffres non audités) M€Exercice 2025Exercice 2024Évolution1er trimestre (janv. – mars)52,948,1+ 10 %2ème trimestre (avril – juin)52,950,0+ 6 %3ème trimestre (juil. – sept.)52,951,1+ 4 %4ème trimestre (oct. – déc.)53,349,1+ 9 %Total annuel (...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.